SIC 2834 – Pharmaceutical Preparations
Valuation | |
---|---|
Market Cap ($M) | 461.38 |
Enterprise Value ($M) | -69.30 |
Book Value ($M) | 532.84 |
Book Value / Share | 13.15 |
Price / Book | 0.87 |
NCAV ($M) | 505.61 |
NCAV / Share | 12.48 |
Price / NCAV | 0.91 |
Profitability (mra) | |
---|---|
Return on Invested Capital (ROIC) | -0.33 |
Return on Assets (ROA) | -0.49 |
Return on Equity (ROE) | -0.55 |
Liquidity (mrq) | |
---|---|
Quick Ratio | 19.03 |
Current Ratio | 19.03 |
Balance Sheet (mrq) ($M) | |
---|---|
Current Assets | 552.05 |
Assets | 579.27 |
Liabilities | 46.44 |
Debt | n/a |
Equity | n/a |
Income Statement (mra) ($M) | |
---|---|
Revenue | 0.00 |
Operating Income | 0.00 |
Net Income | 0.00 |
Cash Flow Statement (mra) ($M) | |
---|---|
Cash From Operations | 0.00 |
Cash from Investing | 0.00 |
Cash from Financing | 0.00 |
(click for more detail) |
File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
---|---|---|---|---|
13G/A | Alkeon Capital Management Llc | 5.00 | 7.65 | |
13G/A | Fmr Llc | 12.93 | 5.30 | |
13G/A | BlackRock, Inc. | 6.80 | 24.32 |
Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
---|---|---|---|---|
(click for more detail) |
Date | Insider Trades | Code | Shares | Value |
---|---|---|---|---|
(click for more detail) |
File Date | Form | SEC Filings |
---|---|---|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
Short Volume | |||
---|---|---|---|
Market Date | Short Volume | Total Volume | Short Volume Ratio |
309,527 | 1,544,940 | 20.03 | |
461,816 | 2,291,603 | 20.15 | |
446,779 | 2,201,099 | 20.30 | |
(click for more detail) |
Similar Companies | |
---|---|
KALV – KalVista Pharmaceuticals, Inc. | KLTO – Klotho Neurosciences, Inc. |
KOD – Kodiak Sciences Inc. | KYMR – Kymera Therapeutics, Inc. |
LGND – Ligand Pharmaceuticals Incorporated |
Financial data and stock pages provided by
Fintel.io